tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Prescient Wins EU Orphan Status for PTX‑100, Advances Global CTCL Trial and Cell Therapy Platforms
Company AnnouncementsPrescient Wins EU Orphan Status for PTX‑100, Advances Global CTCL Trial and Cell Therapy Platforms
1d ago
PTX
Prescient Therapeutics Issues 21.78m Unquoted Options Under Employee Incentive Plan
PremiumCompany Announcements
Prescient Therapeutics Issues 21.78m Unquoted Options Under Employee Incentive Plan
1M ago
PTX
Prescient Therapeutics Gains EU Approval for PTX-100 CTCL Trial
PremiumCompany Announcements
Prescient Therapeutics Gains EU Approval for PTX-100 CTCL Trial
2M ago
PTX
Prescient Therapeutics Announces Director’s Interest Change
PremiumCompany Announcements
Prescient Therapeutics Announces Director’s Interest Change
2M ago
PTX
Prescient Therapeutics Announces Director’s Change in Securities Interest
PremiumCompany Announcements
Prescient Therapeutics Announces Director’s Change in Securities Interest
2M ago
PTX
Director’s Interest Update at Prescient Therapeutics
PremiumCompany AnnouncementsDirector’s Interest Update at Prescient Therapeutics
2M ago
PTX
Prescient Therapeutics Announces Director’s Acquisition of Options
Premium
Company Announcements
Prescient Therapeutics Announces Director’s Acquisition of Options
2M ago
PTX
Prescient Therapeutics Director Acquires New Options
Premium
Company Announcements
Prescient Therapeutics Director Acquires New Options
2M ago
PTX
Prescient Therapeutics Gains EU Orphan Drug Designation for PTX-100
PremiumCompany Announcements
Prescient Therapeutics Gains EU Orphan Drug Designation for PTX-100
2M ago
PTX
Prescient Therapeutics Issues New Employee Incentive Options
PremiumCompany Announcements
Prescient Therapeutics Issues New Employee Incentive Options
2M ago
PTX
Prescient Therapeutics Amends Constitution to Support Strategic Goals
PremiumCompany Announcements
Prescient Therapeutics Amends Constitution to Support Strategic Goals
3M ago
PTX
Prescient Therapeutics Advances PTX-100 Study for CTCL Treatment
PremiumCompany Announcements
Prescient Therapeutics Advances PTX-100 Study for CTCL Treatment
3M ago
PTX
Prescient Therapeutics Advances PTX-100 with Strategic Milestones
PremiumCompany AnnouncementsPrescient Therapeutics Advances PTX-100 with Strategic Milestones
4M ago
PTX
Prescient Therapeutics Bolsters Cash Reserves and Advances Cancer Therapy Trials
Premium
Company Announcements
Prescient Therapeutics Bolsters Cash Reserves and Advances Cancer Therapy Trials
4M ago
PTX
Prescient Therapeutics Announces Hybrid Annual General Meeting
Premium
Company Announcements
Prescient Therapeutics Announces Hybrid Annual General Meeting
5M ago
PTX
Prescient Therapeutics Issues New Unquoted Equity Securities
PremiumCompany Announcements
Prescient Therapeutics Issues New Unquoted Equity Securities
5M ago
PTX
Prescient Therapeutics Completes $3 Million Share Placement to Advance Cancer Therapies
PremiumCompany Announcements
Prescient Therapeutics Completes $3 Million Share Placement to Advance Cancer Therapies
5M ago
PTX
Prescient Therapeutics Lists New Securities on ASX
PremiumCompany Announcements
Prescient Therapeutics Lists New Securities on ASX
5M ago
PTX
Prescient Therapeutics Releases Corporate Governance Statement
PremiumCompany Announcements
Prescient Therapeutics Releases Corporate Governance Statement
5M ago
PTX
Prescient Therapeutics Reports Financial Results with Focus on R&D Investment
PremiumCompany AnnouncementsPrescient Therapeutics Reports Financial Results with Focus on R&D Investment
5M ago
PTX
Prescient Therapeutics Advances Share Placement to Bolster Cancer Therapy Development
Premium
Company Announcements
Prescient Therapeutics Advances Share Placement to Bolster Cancer Therapy Development
6M ago
PTX
Prescient Therapeutics Expands Market Presence with New Securities Quotation
Premium
Company Announcements
Prescient Therapeutics Expands Market Presence with New Securities Quotation
6M ago
PTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >